Effect of a remotely delivered tailored multicomponent approach to enhance medication taking

A recent study investigated whether a remotely delivered multicomponent behaviorally tailored intervention improves medication adherence for people with hyperlipidemia, hypertension, and diabetes.

A recent study investigated whether a remotely delivered multicomponent behaviorally tailored intervention improves medication adherence for people with hyperlipidemia, hypertension, and diabetes. The Study of a Telepharmacy Intervention for Chronic Diseases to Improve Treatment Adherence trial involved more than 4,000 individuals aged 18–85 years with suboptimal hyperlipidemia, hypertension, or diabetes disease control, and who were nonadherent to prescribed medications for these conditions. Among 14 practice sites, 7 were randomized to usual care and 7 received multicomponent tailored interventions involving telephone-delivered behavioral interviewing by trained clinical pharmacists, text messaging, pillboxes, and mailed progress reports. Compared with usual care, the intervention resulted in a 4.7% increase in medication adherence 12 months after randomization, the researchers found; however, there was no difference in the likelihood of achieving good disease control for at least one or all eligible conditions. Intervention participants were also much less likely to visit the emergency department, but rates of hospitalizations or physician office visits were not affected.